Healthcare

Shares of Psychiatric Solutions climbed as much as 25 percent on Wednesday afternoon after The Wall Street Journal reported that the company, which operates mental health hospitals and clinics, was in negotiations be acquired by the private equity firm Bain Capital.

Shares of Psychiatric Solutions climbed as much as 25 percent on Wednesday afternoon after The Wall Street Journal reported that the company, which operates mental health hospitals and clinics, was in negotiations be acquired by the private equity firm Bain Capital.

Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, including for treatments for multiple sclerosis.

Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, including for treatments for multiple sclerosis.